Developing and financing neglected disease vaccines in our new era of "blue marble health" and the anthropocene epoch

Peter J Hotez

doi:10.1016/j.vaccine.2017.02.002

Developing and financing neglected disease vaccines in our new era of "blue marble health" and the anthropocene epoch

Vaccine. 2017 Sep 25;35(40):5403-5405. doi: 10.1016/j.vaccine.2017.02.002. Epub 2017 Mar 3.

Author

Peter J Hotez¹

Affiliation

¹ Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; James A Baker III Institute for Public Policy, Rice University, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, TX, USA. Electronic address: hotez@bcm.edu.

Abstract

New findings of widespread neglected diseases among the poor living in wealthy group of 20 (G20) economies and the concept of "blue marble health" offer innovative mechanisms for financing urgently new vaccines, especially for vector-borne neglected tropical diseases (NTDs). This approach could complement or parallel a recently suggested global vaccine development fund for pandemic threats.

MeSH terms

Global Health
Humans
Neglected Diseases / immunology*
Neglected Diseases / prevention & control*
Tropical Climate
Vaccines / immunology*
Vaccines / therapeutic use*

Substances

Vaccines